The quadrivalent HPV vaccine is 888 RMB per dose, and a total of three doses are required to prevent cervical cancer. The quadrivalent vaccine mainly prevents HPV type 16, HPV type 18, HPV type 11, and HPV type 6 infections in clinical practice, and can block about 90% of cervical cancer occurrences in clinical practice. In addition, Asian women with cervical cancer have the majority of HPV 16 HPV 18 infection, so quadrivalent vaccine can prevent HPV infection to some extent, while stopping the occurrence of cervical cancer.